Welcome, Guest
Username: Password: Remember me
General
  • Page:
  • 1
  • 2

TOPIC: Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 28 Jun 2018 08:03 #11982

  • Pelace
  • Pelace's Avatar Topic Author
  • Offline
  • Fresh Boarder
  • Fresh Boarder
  • Posts: 6
  • Thank you received: 0

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 28 Jun 2018 08:50 #11983

  • b767cpt
  • b767cpt's Avatar
  • Offline
  • Gold Boarder
  • Gold Boarder
  • Posts: 236
  • Thank you received: 3
Saw this on the Yahoo Summary, great news but it will take more than this to pump up the pps to their RO asking price.

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 28 Jun 2018 09:26 #11984

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1117
  • Thank you received: 17

b767cpt wrote: Saw this on the Yahoo Summary, great news but it will take more than this to pump up the pps to their RO asking price.


B-7, there will be more news than this before d-day imo.

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 28 Jun 2018 12:47 #11985

  • Wall Street Titan
  • Wall Street Titan's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 821
  • Thank you received: 148
Pre-clinical study? WAY Too little - WAY TOO LATE. Vericel is already treating patients. Watch the video on Epicel. Autologous skin therapy already being commercialized by Vericel. vcel.com/product-portfolio/

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 28 Jun 2018 14:31 #11986

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1117
  • Thank you received: 17

Wall Street Titan wrote: Pre-clinical study? WAY Too little - WAY TOO LATE. Vericel is already treating patients. Watch the video on Epicel. Autologous skin therapy already being commercialized by Vericel. vcel.com/product-portfolio/


So i guess no competition is allowed in the autologous field which you claimed was not the way to go anyway - hmm? - why don't you explain as an expert on ATHX (with multiple SA articles), how the stock could be trading at 1.95 now after being over 3.00 about a month ago????:bash:

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 29 Jun 2018 13:41 #11995

  • Wall Street Titan
  • Wall Street Titan's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 821
  • Thank you received: 148
Simple. When you bought ATHX at $3.00, other investors found out. Your buys of ATHX naturally scared some in to selling. Look no further than the man in the mirror.

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 29 Jun 2018 14:10 #11996

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1117
  • Thank you received: 17

Wall Street Titan wrote: Simple. When you bought ATHX at $3.00, other investors found out. Your buys of ATHX naturally scared some in to selling. Look no further than the man in the mirror.



I knew that you had no logical answer - you never do - also for the record, I paid no where near $3.00 - it's puzzling how SA allows you to write articles for ATHX and years ago CYTX (for which everything you wrote then you now disavow) - unbelievable!:puke:

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 29 Jun 2018 15:30 #11997

  • Wall Street Titan
  • Wall Street Titan's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 821
  • Thank you received: 148
It's more puzzling how Fas let's you write any words on this board. They keep kicking you out of the $ATHX board on Reddit. However, that is not puzzling at all!! :joy:

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 29 Jun 2018 15:42 #11998

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1117
  • Thank you received: 17

Wall Street Titan wrote: It's more puzzling how Fas let's you write any words on this board. They keep kicking you out of the $ATHX board on Reddit. However, that is not puzzling at all!! :joy:


What the hell are you talking about with the Reddit Board - I no longer post on that MB and rarely post on the Yahoo site for ATHX - I guess that you just cannot supply a reasonable explanation for the ATHX decline even though you are the supposed "expert" with SA credentials - what a joke.:bash:

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 02 Jul 2018 08:41 #12001

  • fas
  • fas's Avatar
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3139
  • Thank you received: 1090

Wall Street Titan wrote: Pre-clinical study? WAY Too little - WAY TOO LATE. Vericel is already treating patients. Watch the video on Epicel. Autologous skin therapy already being commercialized by Vericel. vcel.com/product-portfolio/


I did not want to waste any time on this stuff, but maybe a short note will do.

The two products on the page for which you provided a link, are old obsolete technology from the turn of the century, which Genzyme bulldozed past CBER at the turn of the century. I believe the Ortho product was approved after a small study of less than a year. Epicel probably similar. After the acquisition of Genzyme by Sanofi, the French wanted to get rid of the apps and sold them for a few dollars, an apple and an egg to Aastrom , now Vericel.

The stuff is expensive, ineffective and accordingly hardly sells. For me also, since there lacks a scientific basis- BARDA dealt with CYTX in the fall of 2012, because of human studies done by Akita et al. However they insisted on reverse engineering i.e. first provide the scientific pre-clinical basis, which obviously is on animals. Now- the human studies after 6 years of work can take off. The BARDA contract to me, is worth many multiples of the present CYTX market cap and has potent market value in contrast to the Vericel crap.

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 02 Jul 2018 08:53 #12002

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1117
  • Thank you received: 17

fas wrote:

Wall Street Titan wrote: Pre-clinical study? WAY Too little - WAY TOO LATE. Vericel is already treating patients. Watch the video on Epicel. Autologous skin therapy already being commercialized by Vericel. vcel.com/product-portfolio/


I did not want to waste any time on this stuff, but maybe a short note will do.

The two products on the page for which you provided a link, are old obsolete technology from the turn of the century, which Genzyme bulldozed past CBER at the turn of the century. I believe the Ortho product was approved after a small study of less than a year. Epicel probably similar. After the acquisition of Genzyme by Sanofi, the French wanted to get rid of the apps and sold them for a few dollars, an apple and an egg to Aastrom , now Vericel.

The stuff is expensive, ineffective and accordingly hardly sells. For me also, since there lacks a scientific basis- BARDA dealt with CYTX in the fall of 2012, because of human studies done by Akita et al. However they insisted on reverse engineering i.e. first provide the scientific pre-clinical basis, which obviously is on animals. Now- the human studies after 6 years of work can take off. The BARDA contract to me, is worth many multiples of the present CYTX market cap and has potent market value in contrast to the Vericel crap.


Fas, your last sentence says it all - I truly believe that you are totally correct!:yep: :yep: :yep: :yep:

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 02 Jul 2018 19:50 #12003

  • b767cpt
  • b767cpt's Avatar
  • Offline
  • Gold Boarder
  • Gold Boarder
  • Posts: 236
  • Thank you received: 3
Fas, I believe that WST is smart enough to know what you just countered him with and can’t figure out why he would present this information as if it would have a factual bearing. Thank you for your clear counter points.
WST, I can’t figure out what your true motive is in posting this up unless you can present a clear argument to counter Fas’s argument however, I will say that I have dealt with paid bashers for years on another biotech board and my experience with them is that they will throw up any negative crap they believe will stick, to the point of being ludicrous bogus crap.

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 04 Jul 2018 14:03 #12004

  • Wall Street Titan
  • Wall Street Titan's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 821
  • Thank you received: 148
From Vericel's most recent conference call....

"I will now turn to Epicel, which also had another very strong quarter. While Epicel volumes are inherently better based on the small patient population, we have significantly expanded the number of burn centers utilizing Epicel since we've began reinvesting in this franchise and we expect that Epicel volume should continue to grow on an annual basis.

Similar to MACI, we have a set of strategic imperatives to help drive that growth. The first of which is to establish an Epicel treatment protocol in every target burn center that reflects the best practices of the leading burn care surgeons. To support this imperative, we have built new online tools such as a treatment pathway and videos which featured decision points in criteria to help surgeons identify patients earlier and expand the patient types where Epicel can be used.

Our second imperative for Epicel is to increase utilization through peer-to-peer education, both at major conferences and in one-on-one settings. In the first quarter, we piloted a new cadabra [ph] training program with a small number, surgeons at our headquarters and will roll this enhanced training program out and scheduled advancing to second quarter. In addition, our Epicel team was so very busy at the 50th Annual Meeting of the American Burns Association last month. Two posters of patient cases were presented, we held a very well-attended educational program and an advisory board meeting with KOL.

The third strategic imperative for Epicel is to strengthen reimbursement support for our customers. In conjunction with the new Epicel website, epicel.com, we have recently released a coding reimbursement kit that our burn therapy specialist can offer to current and perspective customers along with a reimbursement hotline.

In summary, Epicel is an important life-saving therapy for severe burn patients and it's our mission to continue to expand utilization and reach more patients in critical need."

"Thanks, Gerard. We had a very strong first quarter and a great start to 2018. Our robust revenue growth and margin expansion reflects the success of our commercial teams sales and marketing initiatives together with strong position enthusiasm from MACI and Epicel. We believe that these results positioned the Company well for both near-term and long-term growth."

EPICEL is commercial NOW and gaining market share NOW for Vericel. ...and in case you haven't noticed the shares are up substantially over the last year even AFTER a recent $75 million capital raise. www.nasdaq.com/press-release/vericel-corporation-announces-closing-of-748-million-public-offering-and-full-exercise-of-the-20180605-01153 You can bash Epicel all you want but they have a very healthy head start and are proving it works by actually treating patients and earning real REVENUES.

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 05 Jul 2018 04:06 #12005

  • fas
  • fas's Avatar
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3139
  • Thank you received: 1090
Ray- who is bashing?????? Not me- YOU are. I could not care less for Epicel- they are simply one of many other solutions in the regenerative wound care business.
Epicel has been around for at least 15 years and was also around when BARDA decided to deal with Cytori. So- your statement - all too little and too late, since Epicel is "already on the market" has absolutely nothing to do with the merits of establishing a scientific base for an application ordered by an government agency.

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 05 Jul 2018 07:32 #12006

  • Wall Street Titan
  • Wall Street Titan's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 821
  • Thank you received: 148
...and here is another company with a similar regmed therapy... www.polarityte.com/products/skinte
COOL was recently under attack by a short seller but seems to be moving ahead with this product.

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 05 Jul 2018 07:35 #12007

  • b767cpt
  • b767cpt's Avatar
  • Offline
  • Gold Boarder
  • Gold Boarder
  • Posts: 236
  • Thank you received: 3
So I would ask, why did BARDA go with Cytori and not Epicel?

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 05 Jul 2018 14:57 #12008

  • Wall Street Titan
  • Wall Street Titan's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 821
  • Thank you received: 148
Because cytori treatment has the potential to be deployed rapidly. Important for nuclear event.

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 05 Jul 2018 15:54 #12009

  • rodney.strongg
  • rodney.strongg's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 1117
  • Thank you received: 17

Wall Street Titan wrote: Because cytori treatment has the potential to be deployed rapidly. Important for nuclear event.


Yes, WST has finally admitted that he was wrong - hard to believe- now, if he can only tell us why his darling ATHX is sinking into the sunset, may be he can establish some credibility - I doubt that he has a clue despite being the "expert" on ATHX with multiple SA articles.

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 06 Jul 2018 10:17 #12013

  • rongside
  • rongside's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 353
  • Thank you received: 193
WST - Rapidly deployed speaks to the ability to provide a treatment that is also cost effective. No need for cutting away good skin from a patient who is already sufferring from severe trauma, and having to wait for weeks for the laborious expansion of his cells to occur. The capacity constraints alone are sufficient to make epicel an uncompetitive option.

For a better understanding of how Cytori's burn therapy works take a look at this. It shows in great detail how the RELIEF Burn trial is structured.

clinicaltrials.gov/ProvidedDocs/72/NCT03435172/Prot_000.pdf

For me the single most imporant thing is that as per the above: ''Percent of group with complete wound closure at each assessment through to 12 weeks'' is the key consideration for efficacy.

Admitedly, ..... ''Enrollment is anticipated to be completed over 18 months. For each patient, the study duration will include a 12 month follow-up period. The total duration of the RELIEF Trial is estimated to be 30 months.''

I do not know if management has a sense of urgency or they are certain of accessing capital indefinitely such that they do not press for full enrolment quickly in what is a relatively small sample size. 12 weeks is not long to wait, assuming enrolment is quick. ???????

Also lets not forget that should RELIEF be successful it opens the way to treating a huge range of wound conditions.

How can a company with a trial such as RELIEF funded by the government have a market cap of only $9M, especially with favourable diffuse Scleroderma data, ADRESU, and stability stage testing of ATI-0918, and a plethora of individual investigator trials?

Somehing stinks . :evil: :puke:

Please Log in or Create an account to join the conversation.

Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study 06 Jul 2018 11:12 #12014

  • b767cpt
  • b767cpt's Avatar
  • Offline
  • Gold Boarder
  • Gold Boarder
  • Posts: 236
  • Thank you received: 3
IMHO, someone is manipulating this, trying to beat it down to pick it up for a song. Be the Swiss as Fas suspects, or someone else. I think the sharks have been circling this for quite some time, waiting to bounce at the right moment just before they have a major breakthrough and it is we, the long term share holders that have carried it to this point.

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
  • 2
Time to create page: 0.116 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites